FOXD2-AS1 is overexpressed in bladder cancer, and upregulation of FOXD2-AS1 shows a significant correlation with tumor stage and tumor recurrence (Su et al., 2018). This evidence concerns the gene FOXD2 and urinary bladder carcinoma.